Participation in the INC is open to a wide range of stakeholders including:
Healthcare Professionals: Neonatologists, pediatricians, nurses, and other medical staff involved in neonatal care. Researchers: Scientists and researchers focusing on neonatal disorders and related fields. Industry Representatives: Pharmaceutical and biotechnology companies developing neonatal therapies. Regulatory Bodies: Organizations responsible for approving and monitoring neonatal treatments and devices. Patient Advocacy Groups: Organizations representing the interests of patients and their families.
